These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29053578)

  • 21. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What we have to know about corticosteroids use during Sars-Cov-2 infection.
    Ferraù F; Ceccato F; Cannavò S; Scaroni C
    J Endocrinol Invest; 2021 Apr; 44(4):693-701. PubMed ID: 32860209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice.
    Barna I; Zelena D; Arszovszki AC; Ledent C
    Life Sci; 2004 Oct; 75(24):2959-70. PubMed ID: 15454346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation.
    Aguilera G; Rabadan-Diehl C
    Regul Pept; 2000 Dec; 96(1-2):23-9. PubMed ID: 11102648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.
    Mastorakos G; Ilias I
    Ann N Y Acad Sci; 2003 Nov; 997():136-49. PubMed ID: 14644820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
    Korbonits M; Trainer PJ; Edwards R; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):29-35. PubMed ID: 7641409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Exogenous Cushing's syndrome and glucocorticoid withdrawal].
    Romanholi DJ; Salgado LR
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1280-92. PubMed ID: 18209866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation.
    Hu P; Liu J; Zhao J; Qi XR; Qi CC; Lucassen PJ; Zhou JN
    Transl Psychiatry; 2013 Dec; 3(12):e336. PubMed ID: 24346134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
    Ginsberg AB; Pecoraro NC; Warne JP; Horneman HF; Dallman MF
    Stress; 2010 May; 13(3):248-57. PubMed ID: 20392196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses.
    Houshyar H; Galigniana MD; Pratt WB; Woods JH
    J Neuroendocrinol; 2001 Oct; 13(10):875-86. PubMed ID: 11679056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitization of the Hypothalamic-Pituitary-Adrenal Axis in a Male Rat Chronic Stress Model.
    Franco AJ; Chen C; Scullen T; Zsombok A; Salahudeen AA; Di S; Herman JP; Tasker JG
    Endocrinology; 2016 Jun; 157(6):2346-55. PubMed ID: 27054552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS
    Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.
    Schlaghecke R; Kornely E; Santen RT; Ridderskamp P
    N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioelectronic sensor mimicking the human neuroendocrine system for the detection of hypothalamic-pituitary-adrenal axis hormones in human blood.
    Lee SH; Lee M; Yang H; Cho Y; Hong S; Park TH
    Biosens Bioelectron; 2020 Apr; 154():112071. PubMed ID: 32056965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
    Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
    Vollenweider P; Waeber G
    Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders.
    Martocchia A; Curto M; Toussan L; Stefanelli M; Falaschi P
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):196-204. PubMed ID: 21834781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.